Surreal illustration of heroin injection leading to kidney damage from amyloidosis

Heroin's Hidden Impact: How Injection Drug Use Leads to AA Amyloidosis

Rhea Morgan monogram
Rhea Morgan in Health & Wellness November 2026 • 4 min read.

"Uncover the surprising link between heroin use, recurrent infections, and the development of secondary amyloidosis, a condition that primarily targets the kidneys."


Illicit drug use carries a wide range of well-documented risks, from overdoses and mental health issues to infectious diseases like HIV and hepatitis C. However, a less recognized complication is gaining attention: secondary amyloidosis (AA amyloidosis). This condition arises from chronic inflammation linked to injection drug use, particularly heroin, and can lead to severe organ damage, especially in the kidneys.

The opioid crisis in the United States has fueled a rise in heroin use, with rates nearly doubling between 2002 and 2013. This increase is especially pronounced among women and non-Hispanic whites, groups that historically had lower rates of heroin use. As heroin use continues to climb, it's crucial to understand the broader health consequences, including AA amyloidosis.

This article explores the connection between heroin use, recurrent infections, and AA amyloidosis. We'll delve into a real-life case, explain the underlying mechanisms, and discuss the implications for public health. Understanding this link is essential for healthcare providers and individuals alike in combating the opioid epidemic and its multifaceted health challenges.

AI Search Multiple angles on this topic

Inflammation and Heroin Use

AA amyloidosis may complicate chronic diseases involving ongoing or recurring inflammation, including rheumatoid arthritis, spondyloarthropathy, inflammatory bowel disease, and chronic infections. One heroin-statistics source reports that 902,000 Americans use heroin annually and that 6.25 million have used it at least once in their lifetime. The same source reports that heroin use increased among people aged 12 or older from 2019 to 2020 and that most people who used heroin first misused prescription opioids.

Diagnosing Amyloidosis

Laboratory diagnosis commonly begins with histological and immunological methods, including Congo red staining, immunohistochemistry, immunofluorescence, and immunoelectron microscopy. Reviews describe these methods as part of a broader diagnostic process whose utility, simplicity, availability, sensitivity, specificity, and throughput must be considered. The College of American Pathologists notes that amyloid detection and subtyping vary among laboratories and that evidence remains lacking in some areas.

What is AA Amyloidosis and How Does Heroin Use Contribute?

Surreal illustration of heroin injection leading to kidney damage from amyloidosis

Amyloidosis is a condition characterized by the buildup of abnormal protein deposits (amyloid fibrils) in organs and tissues, disrupting their normal function. AA amyloidosis, specifically, occurs when fragments of serum amyloid A protein (SAA) accumulate. SAA is produced by the liver in response to inflammation. Chronic inflammatory conditions, such as rheumatoid arthritis or inflammatory bowel disease, have long been recognized as triggers for AA amyloidosis.

However, recent studies are highlighting a concerning trend: an increasing number of AA amyloidosis cases are linked to injection drug use, especially heroin. The connection lies in the recurrent infections common among heroin users. These infections, often involving the skin and soft tissues, cause persistent inflammation, driving the overproduction of SAA and increasing the risk of amyloid deposits forming in the kidneys and other organs.

  • Recurrent Infections: Injection drug use, particularly with black tar heroin, often leads to skin and soft tissue infections due to impurities and non-sterile injection practices.
  • Chronic Inflammation: These infections trigger a prolonged inflammatory response, causing the liver to produce excessive amounts of SAA.
  • Amyloid Deposition: Over time, high levels of SAA can lead to the formation and deposition of amyloid fibrils in various organs, most commonly the kidneys.
AI Search Multiple angles on this topic

Recovery and Treatment Commitment

A published case report describes a patient who, eight months after admission, remained committed to being off all illicit drugs. The patient subsequently underwent right total hip replacement. This report illustrates a clinical course involving both substance-use recovery and major orthopedic intervention.

Rare but Serious Disease

Reports associate intravenous and subcutaneous heroin use, including skin popping, with AA amyloidosis. The condition is described as involving deposition of fibrils made from fragments or intact serum amyloid A protein in extracellular tissues. Case reports emphasize that injection drug use and recurrent infections can lead to predominantly renal disease, including nephrotic-range proteinuria and, in some cases, acute kidney injury.

Regional Patterns and Risk

A University of Washington report examined 38 patients diagnosed with AA-type kidney amyloidosis between 2005 and 2015 at Harborview and UW Medical. Among those patients, 14 percent had past or present heroin use. The report stressed that AA-type amyloidosis remains relatively rare even among injection-drug users and stated that, in the Pacific Northwest, developing the disease after heroin use is unlikely.

The kidneys are particularly vulnerable in AA amyloidosis. The amyloid deposits interfere with the kidney's filtering function, leading to proteinuria (protein in the urine), nephrotic syndrome (a severe form of kidney disease), and ultimately, renal failure. Other organs, such as the liver, spleen, and adrenal glands, can also be affected, though less frequently.

Turning the Tide: Prevention and Treatment

The rise of AA amyloidosis linked to heroin use underscores the urgent need for comprehensive strategies to combat the opioid epidemic. Public health initiatives focusing on safe prescribing practices, harm reduction, and accessible treatment options are crucial. Medication-assisted treatment (MAT), which combines medications with counseling and behavioral therapies, can be highly effective in helping individuals overcome opioid dependence and reduce their risk of injection-related complications.

AI Search Multiple angles on this topic

Therapeutics Market Growth

One market analysis projects the amyloidosis therapeutics market will reach USD 6.34 billion by 2035. It gives a projected compound annual growth rate of 8.18 percent for the 2025-to-2035 period. These figures describe projected industry growth rather than a specific treatment advance for heroin-associated AA amyloidosis.

Injection-Related Inflammation

Reports describe AA amyloidosis associated with intravenous or subcutaneous injection of street drugs such as heroin and cocaine. One autopsy case report characterizes its case as the first reported systemic amyloidosis associated with intravenous injection of oral prescription medications and recurrent chronic injection drug-related infections, according to its authors. This context links the disease challenge to both injected substances and persistent infection-related inflammation.

Kidney Failure in Clinical Cases

Amyloidosis can fill the kidneys with clumps of insoluble protein, leaving them unable to filter wastes from the blood. A case report describes systemic AA amyloidosis associated with intravenous injection of oral prescription medications and recurrent chronic injection drug-related infections. Another report describes a patient with polysubstance use disorder, recurrent cutaneous abscesses, spinal diskitis, and septic thrombophlebitis who presented for medical care.

AA amyloidosis figures across different groups

  • 1.6% to 22.5%Post-mortem estimates among people who inject drugs ranged from 1.6% in Germany to 22.5% in Serbia.[1]
  • 5.26% to 50%In kidney-biopsy samples of people who inject drugs with suspected or known kidney disease, reported proportions ranged from 5.26% in Portugal to 50% in Germany.[1]
  • 7 of 150In a separate autopsy survey, renal amyloidosis was found in 7 of 150 people with addiction examined in New York.[2]

What the figures say about kidney findings

The biopsy estimates concern a group already suspected or known to have kidney disease, so they describe findings in a selected clinical population, not the frequency among all people who inject drugs.[1]

The range of post-mortem estimates indicates that reported proportions differ substantially by setting; it does not establish a single prevalence that applies everywhere.[1]

Why estimates differ across settings

A case report describes a proposed mechanism in which recurrent soft-tissue infections trigger liver production of serum amyloid A; it also links secondary injection sites and impurities in black tar heroin to the setting in which such infections occur. This is a mechanistic account, not a population estimate.[3]

What evidence could clarify the estimates

  • How reliably can prevalence be estimated across people who inject drugs when the literature itself makes those estimates difficult?[1]

Sources

  1. Drawing attention to a neglected injecting-related harm: a systematic review of AA amyloidosis among people who inject drugs. (pubmed.ncbi.nlm.nih.gov)
  2. AA protein-related renal amyloidosis in drug addicts. (pubmed.ncbi.nlm.nih.gov)
  3. Secondary amyloidosis associated with heroin use and recurrent infections – A case report (pmc.ncbi.nlm.nih.gov)

About this Article -

Written with AI assistance from published research, and reviewed by the Mystum team. See our About page for more information.

Everything You Need To Know

1

What exactly is AA Amyloidosis, and how does heroin use play a role in its development?

AA Amyloidosis is a condition where amyloid fibrils, made from fragments of serum amyloid A protein (SAA), build up in organs and tissues, disrupting their normal function. SAA is produced by the liver in response to inflammation. Heroin use contributes because recurrent infections common among users cause persistent inflammation, leading to overproduction of SAA. This increases the risk of amyloid deposits forming, particularly in the kidneys. While the kidneys are most commonly affected, other organs like the liver and spleen can also be impacted by these deposits. Understanding this connection is crucial for addressing the health consequences associated with injection drug use.

2

Why do recurrent infections occur so frequently in heroin users, and how do these infections contribute to AA Amyloidosis?

Recurrent infections in heroin users happen because of impurities in the drugs and non-sterile injection practices. These infections trigger a continuous inflammatory response, causing the liver to produce excessive amounts of serum amyloid A protein (SAA). Over time, high levels of SAA can lead to the formation and deposition of amyloid fibrils in organs. This process is significant because it highlights how injection practices directly contribute to the development of AA amyloidosis, a condition that can severely damage organs, especially the kidneys. Prevention strategies should include promoting safe injection practices and providing resources for treating infections promptly.

3

How does AA Amyloidosis specifically affect the kidneys, and what kind of damage can it cause?

When amyloid deposits build up in the kidneys, they interfere with the kidney's ability to filter waste. This leads to proteinuria, where protein leaks into the urine, and can progress to nephrotic syndrome, a severe form of kidney disease. Eventually, this can cause renal failure, where the kidneys can no longer function adequately. The kidney damage is a major concern in AA amyloidosis because the kidneys are particularly vulnerable to amyloid deposition. Recognizing and treating the condition early can help slow the progression of kidney damage and improve outcomes. Other organs such as the liver and spleen can also be affected.

4

What is Medication-Assisted Treatment (MAT), and why is it considered important in addressing heroin addiction and preventing AA Amyloidosis?

Medication-assisted treatment (MAT) combines medications with counseling and behavioral therapies to help individuals overcome opioid dependence. MAT is important because it can reduce the risk of injection-related complications, including recurrent infections that lead to AA amyloidosis. By addressing the underlying addiction, MAT helps prevent the cycle of infection, inflammation, and amyloid deposition. Broader public health initiatives such as safe prescribing practices and harm reduction strategies are also crucial in preventing heroin use and its associated health consequences. However, MAT is one of the most effective ways of reducing the risk.

5

Why are public health initiatives so crucial in combating the opioid epidemic and the rise of AA Amyloidosis?

Public health initiatives are vital in combating the opioid epidemic and its associated health problems, including AA amyloidosis. These initiatives should include safe prescribing practices to prevent opioid addiction, harm reduction strategies to reduce the risks associated with drug use, and accessible treatment options for individuals struggling with addiction. Education and awareness campaigns can also help inform people about the risks of heroin use and the importance of seeking help. A comprehensive approach is necessary to address the multifaceted challenges posed by the opioid epidemic and protect public health. These initiatives should focus on prevention, treatment, and harm reduction to effectively address the opioid epidemic.

Newsletter Subscribe

Subscribe to get the latest articles and insights directly in your inbox.